Records containing: Noonan Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-19Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome and to Identify Predictive Factors of Disease Progression
-
CLINICAL_TRIALS study record update · 2026-03-11National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype
-
CLINICAL_TRIALS study record update · 2026-03-03Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 2, Randomized, Multicenter, Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment.
-
CLINICAL_TRIALS study record update · 2026-02-19Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Phase III Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-28Palliative Care Needs of Children With Rare Diseases and Their Families
-
CLINICAL_TRIALS study record update · 2026-01-21Multimodality Imaging (Cardiovascular Magnetic Resonance Imaging, Echocardiography, and Nuclear Medicine Imaging) in the Screening, Diagnosis and Risk Stratification of Rare Cardiomyopathies - a Multicenter Study
-
CLINICAL_TRIALS study record update · 2025-12-18Investigation Into the Natural History and Metabolic and Molecular Basis of RASopathies.
-
CLINICAL_TRIALS study record update · 2025-12-02Hemorrhagic Risk and Hemostasis Disorders in Noonan Syndrome and Related Conditions
-
CLINICAL_TRIALS study record update · 2025-11-21A Study Evaluating the Safety and Efficacy of Once-weekly Dosing of Somapacitan in a Basket Study Design in Paediatric Participants With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome or Idiopathic Short Stature
-
CLINICAL_TRIALS study record update · 2025-09-25French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
-
CLINICAL_TRIALS study record update · 2025-04-25Lymphatic Phenotype in Patients With Noonan Syndrome Without a Clinical History of Lymphatic Disease
-
CLINICAL_TRIALS study record update · 2025-03-21Pain in RASopathies: New Investigative Techniques and Possible Treatments
-
CLINICAL_TRIALS study record update · 2024-08-15MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (MEKinRAS) - Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-08-13Joint and Hematologic Disorders of Noonan Syndrome: French Descriptive Cross-sectional Study (NOORHA)
-
CLINICAL_TRIALS study record update · 2024-04-04Incidence and Molecular Pathogenesis of Solid Tumors in RASopathies
-
CLINICAL_TRIALS study record update · 2024-03-26The Impact of Ras/MAPK Pathway Hyperactivation on Bioenergetic Metabolism and Its Effect on Growth Profile and Bone Metabolism
-
CLINICAL_TRIALS study record update · 2023-09-06GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age
-
CLINICAL_TRIALS study record update · 2023-08-09Genetic Testing of Noonan Subjects Previously Treated With Norditropin® in the GHNOO-1658 Trial
-
CLINICAL_TRIALS study record update · 2023-05-11Treatment With HMG-COA Reductase Inhibitor (Simvastatin) of Growth and Bone Abnormalities in Children With Noonan Syndrome: A Phase III Randomised, Double Blind, Placebo-controlled Therapeutic Trial
-
CLINICAL_TRIALS study record update · 2022-11-14Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
-
CLINICAL_TRIALS study record update · 2021-08-26Consequences of Noonan Syndrome/LEOPARD Syndrome Associated Shp2 Mutations on Different Signaling Pathways Activation: Relationship With Hormonal Sensitivity
-
CLINICAL_TRIALS study record update · 2019-10-14A 52-week, Multi-centre, Randomised, Double-blind, Parallel-group, no Treatment Controlled (Open-label) Trial Investigating the Efficacy and Safety of Two Doses of NN-220 in Short Stature With Noonan Syndrome
-
CLINICAL_TRIALS study record update · 2017-10-12NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®
-
CLINICAL_TRIALS study record update · 2017-01-18Norditropin Treatment in Subjects With Noonan Syndrome. Effects on Linear Growth and Final Height - Data Collection and Follow-up Visit